Loading Now

India weighs tighter curbs on weight-loss drugs, as side-effects surface

India weighs tighter curbs on weight-loss drugs, as side-effects surface

India weighs tighter curbs on weight-loss drugs, as side-effects surface


Some experts say the incidence of such adverse drug reactions is low. “The most prevalent side-effects are gastrointestinal, such as nausea, vomiting, constipation and diarrhea, which are well-documented and affect roughly 10-20% of the patient population,” said Dr. Atul Gogia, a senior consultant in the internal medicine department of Sir Ganga Ram Hospital in New Delhi. “The significance of the ADR data depends entirely on the ‘denominator’ of total users. If 300-400 cases occur among hundreds of thousands of patients, the incidence remains low at less than 1%, though higher rates would warrant serious concern.”

Post Comment